Cargando…

WAO Guideline for the Management of Hereditary Angioedema

Hereditary Angioedema (HAE) is a rare disease and for this reason proper diagnosis and appropriate therapy are often unknown or not available for physicians and other health care providers. For this reason we convened a group of specialists that focus upon HAE from around the world to develop not on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Craig, Timothy, Pürsün, Emel Aygören, Bork, Konrad, Bowen, Tom, Boysen, Henrik, Farkas, Henriette, Grumach, Anete, Katelaris, Constance H, Lockey, Richard, Longhurst, Hilary, Lumry, William, Magerl, Markus, Martinez-Saguer, Immaculada, Ritchie, Bruce, Nast, Alexander, Pawankar, Ruby, Zuraw, Bruce, Maurer, Marcus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Allergy Organization 2012
Materias:	WAO Guideline
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651186/ https://www.ncbi.nlm.nih.gov/pubmed/23282420 http://dx.doi.org/10.1097/WOX.0b013e318279affa

Ejemplares similares

The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update
por: Maurer, Marcus, et al.
Publicado: (2022)

Diagnosis and Treatment of Urticaria and Angioedema: A Worldwide Perspective
por: Sánchez-Borges, Mario, et al.
Publicado: (2012)

Management of patients with hereditary angioedema in Germany: comparison with other countries in the Icatibant Outcome Survey
por: Maurer, M., et al.
Publicado: (2018)

On demand treatment and home therapy of hereditary angioedema in Germany - the Frankfurt experience
por: Aygören-Pürsün, Emel, et al.
Publicado: (2010)

World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update – XIII – Oral immunotherapy for CMA – Systematic review
por: Bognanni, Antonio, et al.
Publicado: (2022)

Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series
por: Maurer, Marcus, et al.
Publicado: (2022)

World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) Guidelines update – IV – A quality appraisal with the AGREE II instrument
por: Stróżyk, Agata, et al.
Publicado: (2022)

World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guidelines update – X – Breastfeeding a baby with cow's milk allergy
por: McWilliam, Vicki, et al.
Publicado: (2023)

Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies
por: Aygören-Pürsün, Emel, et al.
Publicado: (2018)

World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guideline update – VII – Milk elimination and reintroduction in the diagnostic process of cow's milk allergy
por: Meyer, Rosan, et al.
Publicado: (2023)

549 Management of Twenty-Five Pediatric Patients with Hereditary Angioedema (Hae) Undergoing Home Treatment—A Clinical Surveillance Program
por: Martinez-Saguer, Inmaculada, et al.
Publicado: (2012)

Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement
por: Kowalski, Marek L., et al.
Publicado: (2016)

Recommendations for Competency in Allergy Training for Undergraduates Qualifying as Medical Practitioners: A Position Paper of the World Allergy Organization
por: Potter, Paul C, et al.
Publicado: (2009)

The International/Canadian Hereditary Angioedema Guideline
por: Betschel, Stephen, et al.
Publicado: (2019)

Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe
por: Aygören-Pürsün, Emel, et al.
Publicado: (2014)

Case Title: 45 year-old male with recurrent angioedema: WAO international case-based discussions
por: Leiding, Jennifer W, et al.
Publicado: (2014)

Correction to: The International/Canadian Hereditary Angioedema Guideline
por: Betschel, Stephen, et al.
Publicado: (2020)

Canadian hereditary angioedema guideline
por: Betschel, Stephen, et al.
Publicado: (2014)

Risk of angioedema following invasive or surgical procedures in HAE type I and II – the natural history
por: Aygören-Pürsün, E, et al.
Publicado: (2013)

Estimation of EuroQol 5-Dimensions health status utility values in hereditary angioedema
por: Aygören-Pürsün, Emel, et al.
Publicado: (2016)

Sub-Lingual Immunotherapy: World Allergy Organization Position Paper 2009
por: Canonica, G. Walter, et al.
Publicado: (2009)

The hereditary angioedema burden of illness study in Europe (HAE-BOIS-Europe): background and methodology
por: Bygum, Anette, et al.
Publicado: (2012)

Hereditary Angioedema Caused By C1-Esterase Inhibitor Deficiency: A Literature-Based Analysis and Clinical Commentary on Prophylaxis Treatment Strategies
por: Gower, Richard G, et al.
Publicado: (2011)

Angioedema Without Wheals: Challenges in Laboratorial Diagnosis
por: Grumach, Anete S., et al.
Publicado: (2021)

Pharmacokinetics of plasma-derived C1-esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study
por: Martinez-Saguer, Inmaculada, et al.
Publicado: (2014)

Clinical characteristics and burden of illness in patients with hereditary angioedema: findings from a multinational patient survey
por: Mendivil, Joan, et al.
Publicado: (2021)

Current challenges and future opportunities in patient‐focused management of hereditary angioedema: A narrative review
por: Grumach, Anete S., et al.
Publicado: (2023)

HAE international home therapy consensus document
por: Longhurst, Hilary J, et al.
Publicado: (2010)

Individual approach to long-term therapy in patients with hereditary angioedema (HAE-C1-INH): A case series
por: Andarawewa, S., et al.
Publicado: (2022)

The Pathophysiology of Hereditary Angioedema
por: Zuraw, Bruce L
Publicado: (2010)

A randomized trial of human C1 inhibitor prophylaxis in children with hereditary angioedema
por: Aygören‐Pürsün, Emel, et al.
Publicado: (2019)

Evaluation of patient‐reported outcome measures for on‐demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstat
por: Cohn, Danny M., et al.
Publicado: (2023)

Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey
por: Zanichelli, Andrea, et al.
Publicado: (2018)

Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized study
por: Li, H. Henry, et al.
Publicado: (2019)

What is an Allergist? Reconciled Document Incorporating Member Society Comments, September 3, 2007
por: Del Giacco, Sergio, et al.
Publicado: (2008)

Requirements for Physician Competencies in Allergy: Key Clinical Competencies Appropriate for the Care of Patients With Allergic or Immunologic Diseases A Position Statement of the World Allergy Organization
por: Kaliner, Michael A, et al.
Publicado: (2008)

Clinical Use of Probiotics in Pediatric Allergy (cuppa): A World Allergy Organization Position Paper
por: Fiocchi, Alessandro, et al.
Publicado: (2012)

World Allergy Organization Guidelines for the Assessment and Management of Anaphylaxis
por: Simons, F. Estelle R., et al.
Publicado: (2011)

Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines update - III - Cow's milk allergens and mechanisms triggering immune activation
por: Jensen, Sebastian A., et al.
Publicado: (2022)

Allergen immunotherapy on the way to product-based evaluation—a WAO statement
por: Bachert, Claus, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ujqueqq18tqtfis1u15s4pbro0